RARECast
Un pódcast de RARECast - Jueves
548 Episodo
-
Leveraging Technology to Empower Patients and Decentralize Clinical Trials
Publicado: 20/10/2022 -
Equipping The Next-Generation Rare Disease Patient Advocate
Publicado: 13/10/2022 -
How a Family Raced from Diagnosis to Experimental Gene Therapy in Three Years
Publicado: 6/10/2022 -
How One Advocate Went from Losing His Hearing to Being Heard
Publicado: 29/9/2022 -
Building a Pipeline of Therapies to Treat Rare Mineralization Disorders
Publicado: 22/9/2022 -
Advancing an Oral Alternative to Infused and Injected Therapies for HAE
Publicado: 15/9/2022 -
Embracing the Promise of Patient-Centered Biotechnology
Publicado: 8/9/2022 -
Learning to Live with Loss
Publicado: 1/9/2022 -
Using Cryptocurrency to Tap into the Wisdom of Crowds
Publicado: 25/8/2022 -
A Therapy for a Rare Neurodegenerative Disease Moves Towards Regulatory Review
Publicado: 18/8/2022 -
Transforming the Treatment of Neuromuscular Diseases with Next-Gen Oligonucleotides
Publicado: 11/8/2022 -
Teaching the Immune System to Let Medicines Do Their Job
Publicado: 4/8/2022 -
Designing Clinical Trials with the Patient in Mind
Publicado: 28/7/2022 -
Keeping Clinical Trials Running Smoothly
Publicado: 21/7/2022 -
A Vision for Patient-Centric Gene Therapy Development
Publicado: 14/7/2022 -
Using Genetic Testing to Address Disparities in Care for Kidney Disease
Publicado: 7/7/2022 -
Why Reforms to the Accelerated Approval Pathway Threaten Rare Disease Drug Development
Publicado: 30/6/2022 -
A Longstanding Academic-Nonprofit Collaboration Gives Rise to an ALS Drug Company
Publicado: 16/6/2022 -
Targeting Regulatory RNA to Upregulate Gene Expression to Treat Rare Diseases
Publicado: 9/6/2022 -
Developing a New Approach to Treat Rare, Autoimmune Conditions
Publicado: 2/6/2022
RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.
